| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caffeic Acids | 27 | 2016 | 28 | 7.010 |
Why?
|
| Phenylethyl Alcohol | 26 | 2016 | 30 | 6.530 |
Why?
|
| Nitric Oxide | 44 | 2016 | 470 | 4.500 |
Why?
|
| Antioxidants | 32 | 2016 | 333 | 3.690 |
Why?
|
| Superoxide Dismutase | 48 | 2014 | 176 | 3.540 |
Why?
|
| Oxidative Stress | 29 | 2015 | 801 | 2.440 |
Why?
|
| Carbon Monoxide Poisoning | 6 | 2016 | 12 | 2.300 |
Why?
|
| Malondialdehyde | 26 | 2014 | 52 | 1.810 |
Why?
|
| Schizophrenia | 10 | 2020 | 332 | 1.790 |
Why?
|
| Xanthine Oxidase | 25 | 2016 | 39 | 1.570 |
Why?
|
| Reperfusion Injury | 11 | 2016 | 110 | 1.460 |
Why?
|
| Glutathione Peroxidase | 24 | 2014 | 47 | 1.400 |
Why?
|
| Adenosine Deaminase | 15 | 2007 | 89 | 1.240 |
Why?
|
| Bipolar Disorder | 4 | 2020 | 369 | 1.000 |
Why?
|
| Oxidants | 7 | 2014 | 25 | 0.990 |
Why?
|
| Cisplatin | 7 | 2015 | 282 | 0.990 |
Why?
|
| Catalase | 21 | 2007 | 64 | 0.980 |
Why?
|
| Myringosclerosis | 2 | 2015 | 2 | 0.950 |
Why?
|
| Antineoplastic Agents | 7 | 2015 | 1829 | 0.950 |
Why?
|
| NF-kappa B | 4 | 2015 | 454 | 0.940 |
Why?
|
| Melatonin | 2 | 2016 | 30 | 0.900 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2015 | 305 | 0.820 |
Why?
|
| Lipid Peroxidation | 9 | 2013 | 93 | 0.800 |
Why?
|
| Reactive Oxygen Species | 11 | 2016 | 516 | 0.790 |
Why?
|
| Lipoprotein(a) | 2 | 2024 | 138 | 0.790 |
Why?
|
| Thioglycolates | 7 | 2008 | 12 | 0.780 |
Why?
|
| Apoptosis | 4 | 2024 | 1899 | 0.760 |
Why?
|
| Lipoproteins, LDL | 5 | 2025 | 133 | 0.750 |
Why?
|
| Thiophenes | 7 | 2008 | 69 | 0.750 |
Why?
|
| Erythrocytes | 8 | 2010 | 201 | 0.740 |
Why?
|
| Zinc | 6 | 2013 | 125 | 0.740 |
Why?
|
| Rats | 31 | 2016 | 3604 | 0.710 |
Why?
|
| Biogenic Amines | 1 | 2021 | 20 | 0.700 |
Why?
|
| Cardiovascular Diseases | 5 | 2025 | 2087 | 0.700 |
Why?
|
| Polyamines | 1 | 2021 | 31 | 0.690 |
Why?
|
| Fatty Liver | 2 | 2013 | 211 | 0.690 |
Why?
|
| Animals | 52 | 2024 | 34823 | 0.670 |
Why?
|
| Copper | 5 | 2004 | 75 | 0.650 |
Why?
|
| Rats, Wistar | 20 | 2014 | 329 | 0.630 |
Why?
|
| Eye Diseases | 3 | 2014 | 116 | 0.630 |
Why?
|
| Atherosclerosis | 2 | 2025 | 1006 | 0.620 |
Why?
|
| Central Nervous System | 2 | 2016 | 283 | 0.620 |
Why?
|
| Psychotic Disorders | 3 | 2014 | 150 | 0.610 |
Why?
|
| Versicans | 2 | 2016 | 17 | 0.610 |
Why?
|
| Terminology as Topic | 1 | 2021 | 232 | 0.610 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 9 | 2008 | 20 | 0.600 |
Why?
|
| Methanol | 3 | 2013 | 16 | 0.590 |
Why?
|
| Hyperbaric Oxygenation | 2 | 2015 | 21 | 0.580 |
Why?
|
| Humans | 86 | 2025 | 132055 | 0.560 |
Why?
|
| Metabolomics | 1 | 2021 | 479 | 0.530 |
Why?
|
| Nails | 3 | 2013 | 21 | 0.520 |
Why?
|
| Myocardium | 2 | 2016 | 907 | 0.520 |
Why?
|
| Bone Resorption | 1 | 2016 | 52 | 0.510 |
Why?
|
| ADAMTS1 Protein | 1 | 2016 | 16 | 0.510 |
Why?
|
| Matrix Metalloproteinases | 1 | 2016 | 63 | 0.510 |
Why?
|
| Poisoning | 2 | 2013 | 18 | 0.510 |
Why?
|
| ADAMTS13 Protein | 1 | 2016 | 66 | 0.500 |
Why?
|
| Accidents | 2 | 2013 | 15 | 0.490 |
Why?
|
| Male | 65 | 2016 | 64944 | 0.490 |
Why?
|
| Pathology | 1 | 2016 | 37 | 0.490 |
Why?
|
| Protective Agents | 3 | 2006 | 36 | 0.480 |
Why?
|
| Neuroprotective Agents | 4 | 2004 | 161 | 0.480 |
Why?
|
| Solvents | 2 | 2013 | 44 | 0.480 |
Why?
|
| Peroxidase | 7 | 2004 | 64 | 0.480 |
Why?
|
| Hematologic Diseases | 1 | 2016 | 82 | 0.480 |
Why?
|
| Bleomycin | 3 | 2004 | 113 | 0.480 |
Why?
|
| Turkey | 5 | 2013 | 67 | 0.480 |
Why?
|
| Bloodletting | 1 | 2015 | 5 | 0.480 |
Why?
|
| Antidotes | 1 | 2015 | 14 | 0.470 |
Why?
|
| Hair Cells, Auditory | 1 | 2015 | 65 | 0.470 |
Why?
|
| Tympanic Membrane | 1 | 2015 | 22 | 0.470 |
Why?
|
| Osteoporosis | 1 | 2016 | 138 | 0.470 |
Why?
|
| Retinitis | 1 | 2015 | 16 | 0.470 |
Why?
|
| Uveitis | 1 | 2015 | 38 | 0.460 |
Why?
|
| von Willebrand Factor | 1 | 2016 | 192 | 0.460 |
Why?
|
| Peptides | 4 | 2004 | 844 | 0.450 |
Why?
|
| Female | 66 | 2016 | 70691 | 0.450 |
Why?
|
| Pulmonary Fibrosis | 3 | 2004 | 112 | 0.450 |
Why?
|
| Ethanol | 2 | 2013 | 162 | 0.440 |
Why?
|
| Polymorphism, Genetic | 4 | 2007 | 803 | 0.440 |
Why?
|
| Otitis Media | 1 | 2015 | 90 | 0.440 |
Why?
|
| Liver | 3 | 2013 | 1797 | 0.440 |
Why?
|
| Carbon Dioxide | 1 | 2015 | 275 | 0.430 |
Why?
|
| Disease Models, Animal | 12 | 2015 | 4683 | 0.430 |
Why?
|
| Adult | 40 | 2016 | 31557 | 0.420 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2007 | 764 | 0.420 |
Why?
|
| Middle Aged | 41 | 2016 | 28979 | 0.410 |
Why?
|
| Magnesium | 3 | 2010 | 114 | 0.410 |
Why?
|
| Behcet Syndrome | 2 | 2004 | 17 | 0.410 |
Why?
|
| Manganese | 7 | 2004 | 58 | 0.410 |
Why?
|
| alpha-Tocopherol | 3 | 2004 | 36 | 0.400 |
Why?
|
| Trace Elements | 3 | 2004 | 24 | 0.390 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 273 | 0.390 |
Why?
|
| Propolis | 4 | 2015 | 4 | 0.380 |
Why?
|
| Myocardial Infarction | 4 | 2016 | 1062 | 0.380 |
Why?
|
| Adrenomedullin | 4 | 2007 | 80 | 0.380 |
Why?
|
| Mitochondria | 2 | 2016 | 751 | 0.370 |
Why?
|
| Prefrontal Cortex | 1 | 2014 | 218 | 0.360 |
Why?
|
| Spermatic Cord Torsion | 2 | 2002 | 16 | 0.360 |
Why?
|
| Neoplasms, Experimental | 1 | 2012 | 218 | 0.350 |
Why?
|
| Magnesium Deficiency | 1 | 2010 | 12 | 0.340 |
Why?
|
| Arginine | 2 | 2004 | 343 | 0.340 |
Why?
|
| Kidney | 6 | 2004 | 1338 | 0.340 |
Why?
|
| Epilepsy | 3 | 2004 | 891 | 0.330 |
Why?
|
| Biomarkers, Tumor | 3 | 2016 | 1683 | 0.330 |
Why?
|
| Acute Kidney Injury | 3 | 2014 | 670 | 0.320 |
Why?
|
| Head and Neck Neoplasms | 2 | 2007 | 615 | 0.320 |
Why?
|
| Autistic Disorder | 2 | 2003 | 387 | 0.310 |
Why?
|
| Inflammation | 2 | 2025 | 1522 | 0.300 |
Why?
|
| Testis | 2 | 2002 | 423 | 0.300 |
Why?
|
| Fibromyalgia | 2 | 2005 | 21 | 0.300 |
Why?
|
| Anticonvulsants | 2 | 2004 | 390 | 0.300 |
Why?
|
| Biomarkers | 13 | 2016 | 3403 | 0.290 |
Why?
|
| Smoking | 2 | 2004 | 940 | 0.280 |
Why?
|
| Adolescent | 19 | 2016 | 20530 | 0.280 |
Why?
|
| Aged, 80 and over | 7 | 2016 | 7125 | 0.280 |
Why?
|
| Hydroxyproline | 3 | 2004 | 7 | 0.280 |
Why?
|
| Antidepressive Agents | 3 | 2007 | 327 | 0.280 |
Why?
|
| Case-Control Studies | 11 | 2007 | 3414 | 0.280 |
Why?
|
| Sex Distribution | 3 | 2013 | 323 | 0.270 |
Why?
|
| Free Radical Scavengers | 3 | 2004 | 58 | 0.270 |
Why?
|
| Exfoliation Syndrome | 1 | 2007 | 5 | 0.270 |
Why?
|
| Spinal Cord Injuries | 2 | 2014 | 261 | 0.260 |
Why?
|
| Aged | 18 | 2016 | 21456 | 0.260 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 3 | 2021 | 420 | 0.260 |
Why?
|
| Dehydroepiandrosterone | 1 | 2007 | 33 | 0.260 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 1348 | 0.250 |
Why?
|
| Cell Phone | 2 | 2004 | 36 | 0.250 |
Why?
|
| Formaldehyde | 1 | 2006 | 39 | 0.250 |
Why?
|
| Hydrocortisone | 1 | 2007 | 226 | 0.240 |
Why?
|
| Melanoma | 1 | 2012 | 954 | 0.230 |
Why?
|
| Benzopyrans | 1 | 2004 | 20 | 0.230 |
Why?
|
| Cardiotonic Agents | 1 | 2006 | 136 | 0.230 |
Why?
|
| Ethanolamines | 1 | 2004 | 25 | 0.220 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 1285 | 0.220 |
Why?
|
| Carbon Monoxide | 2 | 2016 | 25 | 0.220 |
Why?
|
| Fetal Blood | 1 | 2005 | 172 | 0.220 |
Why?
|
| Air Pollutants | 1 | 2006 | 114 | 0.220 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2004 | 8 | 0.220 |
Why?
|
| Tyrosine | 1 | 2004 | 148 | 0.220 |
Why?
|
| Brain | 7 | 2016 | 3191 | 0.220 |
Why?
|
| Endonucleases | 1 | 2004 | 50 | 0.220 |
Why?
|
| Lung Neoplasms | 2 | 2012 | 1540 | 0.210 |
Why?
|
| Fatty Acids, Essential | 1 | 2003 | 6 | 0.210 |
Why?
|
| Spinal Cord Ischemia | 2 | 2004 | 30 | 0.210 |
Why?
|
| Vitamin B 12 | 1 | 2004 | 62 | 0.210 |
Why?
|
| Statistics, Nonparametric | 5 | 2007 | 437 | 0.210 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 1577 | 0.210 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2003 | 15 | 0.210 |
Why?
|
| Homocysteine | 1 | 2004 | 120 | 0.210 |
Why?
|
| Central Nervous System Diseases | 1 | 2004 | 109 | 0.200 |
Why?
|
| Forensic Toxicology | 2 | 2013 | 2 | 0.200 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2003 | 9 | 0.200 |
Why?
|
| Therapeutic Irrigation | 1 | 2003 | 45 | 0.200 |
Why?
|
| Contrast Sensitivity | 1 | 2003 | 43 | 0.200 |
Why?
|
| Carboxyhemoglobin | 2 | 2013 | 9 | 0.200 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2004 | 223 | 0.200 |
Why?
|
| Radiation | 1 | 2002 | 3 | 0.200 |
Why?
|
| Valproic Acid | 1 | 2004 | 163 | 0.200 |
Why?
|
| Myocardial Ischemia | 1 | 2006 | 341 | 0.200 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2003 | 74 | 0.200 |
Why?
|
| Delivery, Obstetric | 1 | 2005 | 260 | 0.200 |
Why?
|
| Amniotic Fluid | 1 | 2003 | 154 | 0.190 |
Why?
|
| Cesarean Section | 1 | 2005 | 407 | 0.190 |
Why?
|
| Dietary Fats | 1 | 2003 | 279 | 0.180 |
Why?
|
| Age Distribution | 2 | 2013 | 433 | 0.180 |
Why?
|
| Folic Acid | 1 | 2004 | 289 | 0.180 |
Why?
|
| Vasodilator Agents | 1 | 2003 | 208 | 0.180 |
Why?
|
| Depressive Disorder, Major | 1 | 2007 | 452 | 0.180 |
Why?
|
| Free Radicals | 6 | 2004 | 33 | 0.180 |
Why?
|
| Seasons | 2 | 2013 | 328 | 0.170 |
Why?
|
| Dizocilpine Maleate | 2 | 2014 | 18 | 0.170 |
Why?
|
| Semen | 1 | 2001 | 81 | 0.170 |
Why?
|
| Varicocele | 1 | 2001 | 61 | 0.170 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2003 | 541 | 0.160 |
Why?
|
| Neural Tube Defects | 1 | 2003 | 357 | 0.160 |
Why?
|
| Macular Degeneration | 1 | 2001 | 127 | 0.160 |
Why?
|
| Hair | 1 | 1999 | 28 | 0.160 |
Why?
|
| Young Adult | 4 | 2016 | 9938 | 0.150 |
Why?
|
| Clinical Enzyme Tests | 2 | 2002 | 16 | 0.150 |
Why?
|
| Seizures | 1 | 2004 | 895 | 0.150 |
Why?
|
| Fetal Diseases | 1 | 2003 | 461 | 0.150 |
Why?
|
| Laryngeal Neoplasms | 3 | 1994 | 91 | 0.150 |
Why?
|
| Nitrites | 3 | 2004 | 49 | 0.150 |
Why?
|
| Rabbits | 4 | 2004 | 673 | 0.150 |
Why?
|
| Spinal Cord | 4 | 2004 | 276 | 0.150 |
Why?
|
| Iron | 3 | 2013 | 302 | 0.150 |
Why?
|
| Appendicitis | 1 | 2000 | 137 | 0.140 |
Why?
|
| Child, Preschool | 7 | 2013 | 14719 | 0.130 |
Why?
|
| RNA-Binding Proteins | 1 | 2002 | 604 | 0.130 |
Why?
|
| Asthma | 2 | 2004 | 772 | 0.130 |
Why?
|
| Hypoxanthine | 1 | 2016 | 7 | 0.130 |
Why?
|
| Head Injuries, Closed | 2 | 2007 | 45 | 0.120 |
Why?
|
| Microdialysis | 1 | 2016 | 57 | 0.120 |
Why?
|
| Propofol | 2 | 2007 | 50 | 0.120 |
Why?
|
| Larynx | 2 | 1994 | 75 | 0.120 |
Why?
|
| Caveolin 1 | 1 | 2016 | 50 | 0.120 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 768 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1993 | 0.120 |
Why?
|
| Superoxides | 1 | 2016 | 133 | 0.120 |
Why?
|
| Erythropoietin | 2 | 2007 | 107 | 0.120 |
Why?
|
| Valine | 2 | 2007 | 111 | 0.120 |
Why?
|
| Prospective Studies | 5 | 2004 | 6556 | 0.120 |
Why?
|
| Uric Acid | 1 | 2016 | 110 | 0.120 |
Why?
|
| Alanine | 2 | 2007 | 158 | 0.120 |
Why?
|
| Severity of Illness Index | 4 | 2006 | 3086 | 0.110 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2005 | 46 | 0.110 |
Why?
|
| Oxidation-Reduction | 2 | 2014 | 436 | 0.110 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2014 | 11 | 0.110 |
Why?
|
| Disease Progression | 3 | 2016 | 2232 | 0.110 |
Why?
|
| Forecasting | 1 | 2016 | 372 | 0.110 |
Why?
|
| Hypoxia | 1 | 2016 | 259 | 0.110 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2006 | 130 | 0.110 |
Why?
|
| Gene Frequency | 2 | 2007 | 750 | 0.110 |
Why?
|
| ADAM Proteins | 1 | 2014 | 84 | 0.110 |
Why?
|
| Bees | 1 | 2014 | 52 | 0.110 |
Why?
|
| Dyslipidemias | 1 | 2016 | 241 | 0.100 |
Why?
|
| Infant | 5 | 2013 | 13037 | 0.100 |
Why?
|
| Models, Theoretical | 1 | 2016 | 388 | 0.100 |
Why?
|
| Infant, Newborn | 3 | 2013 | 8539 | 0.100 |
Why?
|
| Gastrointestinal Contents | 1 | 2013 | 13 | 0.100 |
Why?
|
| Cytokines | 2 | 2013 | 1365 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2007 | 351 | 0.100 |
Why?
|
| Angina, Unstable | 1 | 1993 | 52 | 0.100 |
Why?
|
| Metals | 1 | 1994 | 66 | 0.100 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2006 | 229 | 0.100 |
Why?
|
| Mitochondria, Liver | 1 | 2013 | 34 | 0.100 |
Why?
|
| Proteolysis | 1 | 2014 | 195 | 0.100 |
Why?
|
| Pesticides | 1 | 2013 | 30 | 0.100 |
Why?
|
| Narcotics | 1 | 2013 | 61 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2004 | 1224 | 0.100 |
Why?
|
| Liver Function Tests | 1 | 2013 | 103 | 0.100 |
Why?
|
| Child | 7 | 2013 | 25758 | 0.100 |
Why?
|
| Chromatography, Gas | 1 | 2012 | 21 | 0.100 |
Why?
|
| Forensic Pathology | 1 | 2012 | 7 | 0.100 |
Why?
|
| Retrospective Studies | 4 | 2023 | 17367 | 0.100 |
Why?
|
| Oxygen | 1 | 2016 | 569 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1718 | 0.100 |
Why?
|
| Arthralgia | 1 | 2013 | 68 | 0.100 |
Why?
|
| Adipokines | 1 | 2013 | 72 | 0.090 |
Why?
|
| Astrocytes | 1 | 2015 | 270 | 0.090 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2013 | 87 | 0.090 |
Why?
|
| Urban Population | 1 | 2013 | 245 | 0.090 |
Why?
|
| Acidosis | 1 | 2013 | 101 | 0.090 |
Why?
|
| Genotype | 3 | 2007 | 2703 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 1417 | 0.090 |
Why?
|
| Fibrosis | 1 | 2013 | 421 | 0.090 |
Why?
|
| Neoplasm Staging | 2 | 2007 | 1364 | 0.090 |
Why?
|
| Analysis of Variance | 4 | 2007 | 1007 | 0.080 |
Why?
|
| Serum | 1 | 2010 | 43 | 0.080 |
Why?
|
| Hospitals, University | 1 | 2010 | 104 | 0.080 |
Why?
|
| Drug Therapy, Combination | 3 | 2004 | 1177 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2007 | 2312 | 0.080 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2010 | 77 | 0.080 |
Why?
|
| Chronic Disease | 2 | 2007 | 1227 | 0.080 |
Why?
|
| Acute Disease | 2 | 2006 | 1161 | 0.080 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2013 | 215 | 0.080 |
Why?
|
| Leukemia | 1 | 2013 | 372 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 629 | 0.080 |
Why?
|
| Suicide | 1 | 2012 | 203 | 0.080 |
Why?
|
| Glucosephosphate Dehydrogenase | 2 | 2005 | 16 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2004 | 1132 | 0.070 |
Why?
|
| Models, Biological | 2 | 2004 | 1443 | 0.070 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 2 | 2005 | 11 | 0.070 |
Why?
|
| Cataract | 2 | 1999 | 168 | 0.070 |
Why?
|
| Pregnancy | 3 | 2005 | 7536 | 0.070 |
Why?
|
| Vitamin E | 2 | 2004 | 63 | 0.070 |
Why?
|
| Liver Extracts | 1 | 2006 | 1 | 0.060 |
Why?
|
| Spectrum Analysis | 2 | 2006 | 66 | 0.060 |
Why?
|
| Renal Dialysis | 2 | 2013 | 947 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2013 | 898 | 0.060 |
Why?
|
| 5'-Nucleotidase | 3 | 1994 | 21 | 0.060 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2005 | 10 | 0.060 |
Why?
|
| Substance P | 1 | 2005 | 37 | 0.060 |
Why?
|
| Pituitary-Adrenal System | 1 | 2005 | 44 | 0.060 |
Why?
|
| Time Factors | 2 | 2006 | 6442 | 0.060 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2005 | 68 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 2013 | 865 | 0.060 |
Why?
|
| Autonomic Nervous System | 1 | 2005 | 49 | 0.060 |
Why?
|
| Administration, Inhalation | 1 | 2006 | 190 | 0.060 |
Why?
|
| Plant Oils | 1 | 2005 | 34 | 0.060 |
Why?
|
| Panic Disorder | 1 | 2006 | 52 | 0.060 |
Why?
|
| Muscles | 1 | 2005 | 239 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 1670 | 0.060 |
Why?
|
| Reference Values | 3 | 2004 | 703 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 3687 | 0.060 |
Why?
|
| Regional Blood Flow | 1 | 2005 | 212 | 0.060 |
Why?
|
| Demography | 1 | 2006 | 242 | 0.060 |
Why?
|
| Convulsants | 1 | 2004 | 20 | 0.060 |
Why?
|
| Pentylenetetrazole | 1 | 2004 | 30 | 0.060 |
Why?
|
| Nebivolol | 1 | 2004 | 4 | 0.060 |
Why?
|
| Adenosine | 1 | 2006 | 135 | 0.060 |
Why?
|
| Expectorants | 1 | 2004 | 8 | 0.060 |
Why?
|
| Guanidines | 1 | 2004 | 23 | 0.060 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2005 | 45 | 0.060 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2004 | 46 | 0.060 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 48 | 0.060 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2004 | 140 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 1163 | 0.050 |
Why?
|
| Ginkgo biloba | 1 | 2004 | 12 | 0.050 |
Why?
|
| Docosahexaenoic Acids | 1 | 2004 | 66 | 0.050 |
Why?
|
| Prevalence | 1 | 2010 | 2662 | 0.050 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2004 | 81 | 0.050 |
Why?
|
| Health Status | 1 | 2006 | 407 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 128 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 408 | 0.050 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2003 | 44 | 0.050 |
Why?
|
| Corpus Striatum | 1 | 2003 | 96 | 0.050 |
Why?
|
| Fish Oils | 1 | 2003 | 80 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2023 | 128 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2004 | 322 | 0.050 |
Why?
|
| Kidney Tubules | 1 | 2003 | 74 | 0.050 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2002 | 7 | 0.050 |
Why?
|
| Arginase | 1 | 2003 | 35 | 0.050 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2004 | 156 | 0.050 |
Why?
|
| Organ Size | 1 | 2004 | 447 | 0.050 |
Why?
|
| Hearing Loss | 1 | 2005 | 212 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2004 | 135 | 0.050 |
Why?
|
| Blood Chemical Analysis | 1 | 2003 | 86 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2005 | 476 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2004 | 328 | 0.050 |
Why?
|
| Kidney Function Tests | 1 | 2003 | 138 | 0.050 |
Why?
|
| Multiple Myeloma | 1 | 2005 | 202 | 0.050 |
Why?
|
| Collagen | 1 | 2003 | 303 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 228 | 0.050 |
Why?
|
| Nitrates | 1 | 2001 | 33 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2004 | 256 | 0.050 |
Why?
|
| Brain Chemistry | 3 | 2007 | 118 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 3753 | 0.050 |
Why?
|
| Diet | 2 | 2005 | 1125 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2004 | 551 | 0.040 |
Why?
|
| Esophageal Stenosis | 1 | 2001 | 46 | 0.040 |
Why?
|
| Burns, Chemical | 1 | 2001 | 29 | 0.040 |
Why?
|
| Insect Proteins | 1 | 2002 | 111 | 0.040 |
Why?
|
| Antipsychotic Agents | 1 | 2005 | 380 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2001 | 119 | 0.040 |
Why?
|
| Creatinine | 1 | 2003 | 413 | 0.040 |
Why?
|
| Rats, Inbred Strains | 1 | 2000 | 219 | 0.040 |
Why?
|
| Sperm Count | 1 | 2001 | 91 | 0.040 |
Why?
|
| Transferrin | 1 | 2000 | 47 | 0.040 |
Why?
|
| Sperm Motility | 1 | 2001 | 113 | 0.040 |
Why?
|
| DNA | 2 | 2004 | 1478 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 2675 | 0.040 |
Why?
|
| Albumins | 1 | 2000 | 95 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2007 | 1580 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 2669 | 0.040 |
Why?
|
| Alleles | 1 | 2005 | 1684 | 0.040 |
Why?
|
| Sex Factors | 1 | 2004 | 1352 | 0.040 |
Why?
|
| Creatine Kinase | 2 | 2005 | 64 | 0.040 |
Why?
|
| Cytotoxins | 1 | 1999 | 23 | 0.040 |
Why?
|
| Ferritins | 1 | 2000 | 109 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 1999 | 69 | 0.040 |
Why?
|
| Coronary Disease | 2 | 2005 | 685 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 3770 | 0.040 |
Why?
|
| Lung | 2 | 2004 | 1556 | 0.040 |
Why?
|
| Lens Nucleus, Crystalline | 1 | 1999 | 4 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 1999 | 98 | 0.040 |
Why?
|
| Chromium | 1 | 1999 | 7 | 0.040 |
Why?
|
| Aluminum | 1 | 1999 | 14 | 0.040 |
Why?
|
| Spermatozoa | 1 | 2001 | 243 | 0.040 |
Why?
|
| Critical Illness | 1 | 2023 | 617 | 0.040 |
Why?
|
| Prenatal Diagnosis | 1 | 2003 | 631 | 0.040 |
Why?
|
| Nickel | 1 | 1999 | 24 | 0.040 |
Why?
|
| Alopecia | 1 | 1999 | 40 | 0.040 |
Why?
|
| Random Allocation | 3 | 2005 | 431 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 382 | 0.040 |
Why?
|
| Movement | 1 | 1999 | 168 | 0.040 |
Why?
|
| Lens, Crystalline | 1 | 1999 | 106 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2006 | 5407 | 0.040 |
Why?
|
| Pleural Neoplasms | 1 | 1999 | 80 | 0.030 |
Why?
|
| Mesothelioma | 1 | 1999 | 93 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1999 | 145 | 0.030 |
Why?
|
| Infertility, Male | 1 | 2001 | 296 | 0.030 |
Why?
|
| Wound Healing | 1 | 2001 | 475 | 0.030 |
Why?
|
| Prognosis | 1 | 2007 | 5013 | 0.030 |
Why?
|
| Scavenger Receptors, Class E | 1 | 2016 | 9 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2004 | 739 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 1997 | 180 | 0.030 |
Why?
|
| Lipids | 1 | 1999 | 561 | 0.030 |
Why?
|
| Intestines | 1 | 1999 | 606 | 0.030 |
Why?
|
| Calcium | 1 | 2000 | 1079 | 0.030 |
Why?
|
| Hypolipidemic Agents | 1 | 2016 | 189 | 0.030 |
Why?
|
| Brevican | 1 | 2014 | 2 | 0.030 |
Why?
|
| ADAMTS5 Protein | 1 | 2014 | 4 | 0.030 |
Why?
|
| Aggrecans | 1 | 2014 | 6 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 3358 | 0.030 |
Why?
|
| ADAMTS4 Protein | 1 | 2014 | 12 | 0.030 |
Why?
|
| Drug Interactions | 2 | 2005 | 246 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 881 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 1757 | 0.030 |
Why?
|
| Stomach Ulcer | 1 | 1994 | 94 | 0.030 |
Why?
|
| Nitroblue Tetrazolium | 1 | 1993 | 1 | 0.030 |
Why?
|
| Gastritis, Atrophic | 1 | 1994 | 61 | 0.030 |
Why?
|
| Mice | 2 | 2014 | 18488 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1993 | 222 | 0.020 |
Why?
|
| Knee | 1 | 2013 | 22 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2013 | 67 | 0.020 |
Why?
|
| Mitral Valve Stenosis | 1 | 1993 | 39 | 0.020 |
Why?
|
| Coma | 1 | 2013 | 57 | 0.020 |
Why?
|
| Acid-Base Equilibrium | 1 | 2013 | 60 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1994 | 255 | 0.020 |
Why?
|
| Axons | 1 | 2014 | 394 | 0.020 |
Why?
|
| Mitral Valve | 1 | 1993 | 269 | 0.020 |
Why?
|
| Pain Management | 1 | 2013 | 197 | 0.020 |
Why?
|
| Stomach Neoplasms | 1 | 1994 | 565 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 1993 | 1966 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1994 | 815 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 3863 | 0.020 |
Why?
|
| Risk Factors | 2 | 2016 | 10936 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2005 | 27 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1994 | 952 | 0.010 |
Why?
|
| Myelin Basic Protein | 1 | 2005 | 67 | 0.010 |
Why?
|
| Malate Dehydrogenase | 1 | 2004 | 5 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 124 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 2005 | 84 | 0.010 |
Why?
|
| Cell Count | 1 | 2005 | 234 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 4716 | 0.010 |
Why?
|
| Electromagnetic Fields | 1 | 2004 | 26 | 0.010 |
Why?
|
| Vincristine | 1 | 2005 | 196 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 2004 | 71 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 2004 | 118 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 322 | 0.010 |
Why?
|
| Motor Neurons | 1 | 2004 | 134 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 182 | 0.010 |
Why?
|
| Glutathione | 1 | 2005 | 200 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2005 | 303 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2004 | 183 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2013 | 13015 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2005 | 273 | 0.010 |
Why?
|
| Age of Onset | 1 | 2004 | 626 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 749 | 0.010 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2005 | 413 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1999 | 258 | 0.010 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1999 | 5 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 2137 | 0.010 |
Why?
|
| Apolipoproteins A | 1 | 1999 | 54 | 0.010 |
Why?
|
| Apolipoproteins B | 1 | 1999 | 140 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 1999 | 398 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1997 | 99 | 0.010 |
Why?
|
| Angina Pectoris | 1 | 1997 | 68 | 0.010 |
Why?
|
| Depression | 1 | 2005 | 1350 | 0.010 |
Why?
|
| Triglycerides | 1 | 1999 | 617 | 0.010 |
Why?
|
| Cholesterol | 1 | 1999 | 559 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 1999 | 606 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1999 | 796 | 0.010 |
Why?
|
| Gastric Juice | 1 | 1994 | 15 | 0.010 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 1994 | 22 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1994 | 334 | 0.010 |
Why?
|
| Spectrophotometry, Infrared | 1 | 1993 | 26 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1993 | 295 | 0.010 |
Why?
|
| Rheumatic Heart Disease | 1 | 1993 | 38 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 1999 | 893 | 0.010 |
Why?
|
| Calcinosis | 1 | 1993 | 191 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1997 | 996 | 0.010 |
Why?
|